Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Silk Road Medical price target lowered to $55 from $58 at Piper Sandler » 05:17
07/30/21
07/30
05:17
07/30/21
05:17
SILK

Silk Road Medical

$44.43 /

-1.13 (-2.48%)

Piper Sandler analyst…

Piper Sandler analyst Adam Maeder lowered the firm's price target on Silk Road Medical to $55 from $58 and keeps a Neutral rating on the shares. The analyst views the Q2 results as "rock solid" but awaits a "bit more execution."

ShowHide Related Items >><<
SILK Silk Road Medical
$44.43 /

-1.13 (-2.48%)

SILK Silk Road Medical
$44.43 /

-1.13 (-2.48%)

03/02/21 Citi
Silk Road Medical price target lowered to $59 from $64 at Citi
02/04/21 Piper Sandler
Silk Road recall update 'should be received positively,' says Piper Sandler
01/25/21 Piper Sandler
Silk Road Medical recall primarily manufacturing related, says Piper Sandler
01/13/21 Piper Sandler
Piper Sandler sees no 'larger issue in play' following Silk Road Medical recall
SILK Silk Road Medical
$44.43 /

-1.13 (-2.48%)

SILK Silk Road Medical
$44.43 /

-1.13 (-2.48%)

Thursday
Earnings
Silk Road Medical raises FY21 revenue view to $104M-$109M from $103M-$108M » 16:35
07/29/21
07/29
16:35
07/29/21
16:35
SILK

Silk Road Medical

$44.43 /

-1.13 (-2.48%)

Consensus $106.04M. The…

Consensus $106.04M. The company said, "Silk Road Medical projects revenue for the full year 2021 to range from $104 million to $109 million, which represents 38% to 45% growth over the company's prior year revenue. This compares to previous revenue guidance of $103 million to $108 million."

ShowHide Related Items >><<
SILK Silk Road Medical
$44.43 /

-1.13 (-2.48%)

SILK Silk Road Medical
$44.43 /

-1.13 (-2.48%)

03/02/21 Citi
Silk Road Medical price target lowered to $59 from $64 at Citi
02/04/21 Piper Sandler
Silk Road recall update 'should be received positively,' says Piper Sandler
01/25/21 Piper Sandler
Silk Road Medical recall primarily manufacturing related, says Piper Sandler
01/13/21 Piper Sandler
Piper Sandler sees no 'larger issue in play' following Silk Road Medical recall
SILK Silk Road Medical
$44.43 /

-1.13 (-2.48%)

SILK Silk Road Medical
$44.43 /

-1.13 (-2.48%)

Earnings
Silk Road Medical reports Q2 EPS (31c), consensus (36c) » 16:33
07/29/21
07/29
16:33
07/29/21
16:33
SILK

Silk Road Medical

$44.43 /

-1.13 (-2.48%)

Reports Q2 revenue…

Reports Q2 revenue $26.46M, consensus $25.34M. "Our second quarter results reflect excellent commercial execution and broad strength across our business, as TCAR utilization increased in all segments of our trained physician base," said Erica Rogers, President and CEO of Silk Road Medical. "We remain very optimistic about the future of TCAR, and we are particularly excited about the new evidence supporting TCAR in standard surgical risk patients as we prepare to expand our addressable market to include this patient population."

ShowHide Related Items >><<
SILK Silk Road Medical
$44.43 /

-1.13 (-2.48%)

SILK Silk Road Medical
$44.43 /

-1.13 (-2.48%)

03/02/21 Citi
Silk Road Medical price target lowered to $59 from $64 at Citi
02/04/21 Piper Sandler
Silk Road recall update 'should be received positively,' says Piper Sandler
01/25/21 Piper Sandler
Silk Road Medical recall primarily manufacturing related, says Piper Sandler
01/13/21 Piper Sandler
Piper Sandler sees no 'larger issue in play' following Silk Road Medical recall
SILK Silk Road Medical
$44.43 /

-1.13 (-2.48%)

SILK Silk Road Medical
$44.43 /

-1.13 (-2.48%)

Over a month ago
Hot Stocks
Silk Road Medical opens new office in Minnesota » 16:08
06/22/21
06/22
16:08
06/22/21
16:08
SILK

Silk Road Medical

$51.87 /

+0.74 (+1.45%)

Silk Road Medical…

Silk Road Medical announced the opening of a new office in Plymouth, Minnesota, to accommodate growing demand for TransCarotid Artery Revascularization, or TCAR, and to access the local talent pool of aspiring and experienced med tech professionals.

ShowHide Related Items >><<
SILK Silk Road Medical
$51.87 /

+0.74 (+1.45%)

SILK Silk Road Medical
$51.87 /

+0.74 (+1.45%)

03/02/21 Citi
Silk Road Medical price target lowered to $59 from $64 at Citi
02/04/21 Piper Sandler
Silk Road recall update 'should be received positively,' says Piper Sandler
01/25/21 Piper Sandler
Silk Road Medical recall primarily manufacturing related, says Piper Sandler
01/13/21 Piper Sandler
Piper Sandler sees no 'larger issue in play' following Silk Road Medical recall
SILK Silk Road Medical
$51.87 /

+0.74 (+1.45%)

SILK Silk Road Medical
$51.87 /

+0.74 (+1.45%)

Earnings
Silk Road Medical sees FY21 revenue $103M-$108M, consensus $105.46M » 16:31
05/04/21
05/04
16:31
05/04/21
16:31
SILK

Silk Road Medical

$61.21 /

-1.61 (-2.56%)

Silk Road Medical…

Silk Road Medical projects revenue for the full year 2021 to range from $103 million to $108 million. This compares to previous revenue guidance of $102 million to $108 million.

ShowHide Related Items >><<
SILK Silk Road Medical
$61.21 /

-1.61 (-2.56%)

SILK Silk Road Medical
$61.21 /

-1.61 (-2.56%)

03/02/21 Citi
Silk Road Medical price target lowered to $59 from $64 at Citi
02/04/21 Piper Sandler
Silk Road recall update 'should be received positively,' says Piper Sandler
01/25/21 Piper Sandler
Silk Road Medical recall primarily manufacturing related, says Piper Sandler
01/13/21 Piper Sandler
Piper Sandler sees no 'larger issue in play' following Silk Road Medical recall
SILK Silk Road Medical
$61.21 /

-1.61 (-2.56%)

  • 06
    May
SILK Silk Road Medical
$61.21 /

-1.61 (-2.56%)

Earnings
Silk Road Medical reports Q1 EPS (31c), consensus (39c) » 16:29
05/04/21
05/04
16:29
05/04/21
16:29
SILK

Silk Road Medical

$61.21 /

-1.61 (-2.56%)

Reports Q1 revenue…

Reports Q1 revenue $22.1M, consensus $21.3M. "Our first quarter results were characterized by meaningful progress on several commercial and operational initiatives and strong financial performance," said Erica Rogers, President and Chief Executive Officer of Silk Road Medical. "Procedure trends are improving, and we are working closely with our trained physicians to drive adoption of TCAR as the environment normalizes. Simultaneously, we are driving forward development efforts aimed at new indications, therapies, and market opportunities." The company also announced that the FDA has approved an IDE for its feasibility study in acute ischemic stroke, Neuroprotection in Transcarotid Embolectomy (NITE-1).

ShowHide Related Items >><<
SILK Silk Road Medical
$61.21 /

-1.61 (-2.56%)

SILK Silk Road Medical
$61.21 /

-1.61 (-2.56%)

03/02/21 Citi
Silk Road Medical price target lowered to $59 from $64 at Citi
02/04/21 Piper Sandler
Silk Road recall update 'should be received positively,' says Piper Sandler
01/25/21 Piper Sandler
Silk Road Medical recall primarily manufacturing related, says Piper Sandler
01/13/21 Piper Sandler
Piper Sandler sees no 'larger issue in play' following Silk Road Medical recall
SILK Silk Road Medical
$61.21 /

-1.61 (-2.56%)

  • 06
    May
SILK Silk Road Medical
$61.21 /

-1.61 (-2.56%)

Over a quarter ago
Hot Stocks
Silk Road Medical appoints William Hill as general counsel » 16:07
04/15/21
04/15
16:07
04/15/21
16:07
SILK

Silk Road Medical

$51.27 /

-0.14 (-0.27%)

, NTUS

Natus Medical

$28.12 /

-0.48 (-1.68%)

Silk Road Medical (SILK)…

Silk Road Medical (SILK) announced the appointment of William Hill as general counsel. The veteran corporate executive joins the company to oversee all risk management and legal matters, reporting directly to president and CEO, Erica Rogers. Prior to joining Silk Road Medical, Hill served as general counsel for Natus Medical (NTUS) for over 14 years. He was responsible for managing a broad range of global legal issues, including corporate-wide liability mitigation and international legal compliance strategies, mergers and acquisitions, general commercial law and litigation, and employment law.

ShowHide Related Items >><<
SILK Silk Road Medical
$51.27 /

-0.14 (-0.27%)

NTUS Natus Medical
$28.12 /

-0.48 (-1.68%)

SILK Silk Road Medical
$51.27 /

-0.14 (-0.27%)

03/02/21 Citi
Silk Road Medical price target lowered to $59 from $64 at Citi
02/04/21 Piper Sandler
Silk Road recall update 'should be received positively,' says Piper Sandler
01/25/21 Piper Sandler
Silk Road Medical recall primarily manufacturing related, says Piper Sandler
01/13/21 Piper Sandler
Piper Sandler sees no 'larger issue in play' following Silk Road Medical recall
NTUS Natus Medical
$28.12 /

-0.48 (-1.68%)

SILK Silk Road Medical
$51.27 /

-0.14 (-0.27%)

  • 06
    May
SILK Silk Road Medical
$51.27 /

-0.14 (-0.27%)

Conference/Events
Silk Road Medical management to meet virtually with JPMorgan » 04:55
03/22/21
03/22
04:55
03/22/21
04:55
SILK

Silk Road Medical

$49.02 /

-0.22 (-0.45%)

Virtual Meeting to be…

Virtual Meeting to be held on March 22 hosted by JPMorgan.

ShowHide Related Items >><<
SILK Silk Road Medical
$49.02 /

-0.22 (-0.45%)

SILK Silk Road Medical
$49.02 /

-0.22 (-0.45%)

03/02/21 Citi
Silk Road Medical price target lowered to $59 from $64 at Citi
02/04/21 Piper Sandler
Silk Road recall update 'should be received positively,' says Piper Sandler
01/25/21 Piper Sandler
Silk Road Medical recall primarily manufacturing related, says Piper Sandler
01/13/21 Piper Sandler
Piper Sandler sees no 'larger issue in play' following Silk Road Medical recall
SILK Silk Road Medical
$49.02 /

-0.22 (-0.45%)

  • 06
    May
SILK Silk Road Medical
$49.02 /

-0.22 (-0.45%)

Conference/Events
Silk Road Medical management to meet virtually with JPMorgan » 15:34
03/18/21
03/18
15:34
03/18/21
15:34
SILK

Silk Road Medical

$49.66 /

-3.31 (-6.25%)

Virtual Meeting to be…

Virtual Meeting to be held on March 22 hosted by JPMorgan.

ShowHide Related Items >><<
SILK Silk Road Medical
$49.66 /

-3.31 (-6.25%)

SILK Silk Road Medical
$49.66 /

-3.31 (-6.25%)

03/02/21 Citi
Silk Road Medical price target lowered to $59 from $64 at Citi
02/04/21 Piper Sandler
Silk Road recall update 'should be received positively,' says Piper Sandler
01/25/21 Piper Sandler
Silk Road Medical recall primarily manufacturing related, says Piper Sandler
01/13/21 Piper Sandler
Piper Sandler sees no 'larger issue in play' following Silk Road Medical recall
SILK Silk Road Medical
$49.66 /

-3.31 (-6.25%)

  • 06
    May
SILK Silk Road Medical
$49.66 /

-3.31 (-6.25%)

Recommendations
Silk Road Medical price target lowered to $59 from $64 at Citi » 06:25
03/02/21
03/02
06:25
03/02/21
06:25
SILK

Silk Road Medical

$55.35 /

+0.53 (+0.97%)

Citi analyst Joanne…

Citi analyst Joanne Wuensch lowered the firm's price target on Silk Road Medical to $59 from $64 and keeps a Neutral rating on the shares following the Q4 results.

ShowHide Related Items >><<
SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

02/04/21 Piper Sandler
Silk Road recall update 'should be received positively,' says Piper Sandler
01/25/21 Piper Sandler
Silk Road Medical recall primarily manufacturing related, says Piper Sandler
01/13/21 Piper Sandler
Piper Sandler sees no 'larger issue in play' following Silk Road Medical recall
11/11/20 Piper Sandler
Silk Road Medical price target raised to $58 from $54 at Piper Sandler
SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

  • 06
    May
SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.